symbol,statement_type,period_end,line_item,value
SMSPHARMA.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.270089
SMSPHARMA.NS,income,2025-03-31 00:00:00,Normalized EBITDA,1452157000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,343373000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,5234089000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,EBITDA,1452157000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,EBIT,1108784000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Interest Income,-185409000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense,185409000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Interest Income,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Normalized Income,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Total Expenses,6780941000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Basic Average Shares,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Diluted EPS,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Basic EPS,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Income,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,691350000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Tax Provision,249393000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Pretax Income,923375000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,62244000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Other Special Charges,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-185409000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,185409000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Operating Income,1046540000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Operating Expense,1546852000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Other Operating Expenses,402637000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,343373000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Amortization,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,343373000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Research And Development,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Selling General And Administration,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
SMSPHARMA.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
SMSPHARMA.NS,income,2025-03-31 00:00:00,Gross Profit,2593392000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Cost Of Revenue,5234089000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Total Revenue,7827481000.0
SMSPHARMA.NS,income,2025-03-31 00:00:00,Operating Revenue,7827481000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.25575
SMSPHARMA.NS,income,2024-03-31 00:00:00,Normalized EBITDA,1210793000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,315157000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,4977079000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,EBITDA,1210793000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,EBIT,895636000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Interest Income,-234568000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense,234568000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Interest Income,7579000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Normalized Income,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Total Expenses,6241595000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,717000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Diluted Average Shares,84594228.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Basic Average Shares,84594228.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Diluted EPS,5.89
SMSPHARMA.NS,income,2024-03-31 00:00:00,Basic EPS,5.89
SMSPHARMA.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Income,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,498260000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Tax Provision,169068000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Pretax Income,661068000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,44597000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Other Special Charges,-372000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-234568000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,9780000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,234568000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,7579000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Operating Income,851039000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Operating Expense,1264516000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Other Operating Expenses,307862000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,315157000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Amortization,9116000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,315157000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Research And Development,111131000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Selling General And Administration,142059000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,47317000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,General And Administrative Expense,94742000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,717000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Gross Profit,2115555000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Cost Of Revenue,4977079000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Total Revenue,7092634000.0
SMSPHARMA.NS,income,2024-03-31 00:00:00,Operating Revenue,7092634000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-148989.549644
SMSPHARMA.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.273878
SMSPHARMA.NS,income,2023-03-31 00:00:00,Normalized EBITDA,585233000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items,-544000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-544000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,321254000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,3906077000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,EBITDA,584689000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,EBIT,263435000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Interest Income,-211994000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense,209944000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Interest Income,7748000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Normalized Income,-70197989.549644
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Total Expenses,4972654000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,804000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Diluted Average Shares,84652000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Basic Average Shares,84652000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Diluted EPS,-0.83
SMSPHARMA.NS,income,2023-03-31 00:00:00,Basic EPS,-0.83
SMSPHARMA.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Income,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-70593000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Tax Provision,14650000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Pretax Income,53491000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,2166000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Special Income Charges,-544000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Other Special Charges,544000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-211994000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,9798000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,209944000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,7748000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Operating Income,224814000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Operating Expense,1066577000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Other Operating Expenses,46931000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,321254000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Amortization,7087000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,314167000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Research And Development,89192000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Selling General And Administration,93206000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,38227000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,General And Administrative Expense,54979000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,804000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Gross Profit,1291391000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Cost Of Revenue,3906077000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Total Revenue,5197468000.0
SMSPHARMA.NS,income,2023-03-31 00:00:00,Operating Revenue,5197468000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-333.922635
SMSPHARMA.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.009025
SMSPHARMA.NS,income,2022-03-31 00:00:00,Normalized EBITDA,1188119000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items,-37000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-37000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,321525000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,3335860000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,EBITDA,1188082000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,EBIT,866557000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Interest Income,-186043000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense,181566000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Interest Income,5596000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Normalized Income,622235666.077365
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Total Expenses,4325468000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,939000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Diluted Average Shares,84652000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Basic Average Shares,84652000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Diluted EPS,7.35
SMSPHARMA.NS,income,2022-03-31 00:00:00,Basic EPS,7.35
SMSPHARMA.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Income,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,622199000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Tax Provision,6182000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Pretax Income,684991000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,20586000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Special Income Charges,-37000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Other Special Charges,37000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-186043000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,10073000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,181566000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,5596000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Operating Income,824690000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Operating Expense,989608000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Other Operating Expenses,45498000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,321525000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Amortization,7100000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,314425000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Research And Development,
SMSPHARMA.NS,income,2022-03-31 00:00:00,Selling General And Administration,83685000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,34209000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,General And Administrative Expense,49476000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,939000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Gross Profit,1814298000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Cost Of Revenue,3335860000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Total Revenue,5150158000.0
SMSPHARMA.NS,income,2022-03-31 00:00:00,Operating Revenue,5150158000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
SMSPHARMA.NS,income,2021-03-31 00:00:00,EBITDA,
SMSPHARMA.NS,income,2021-03-31 00:00:00,EBIT,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Interest Income,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Interest Income,3144000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Normalized Income,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Total Expenses,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,1043000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Diluted Average Shares,84652000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Basic Average Shares,84652000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Diluted EPS,7.39
SMSPHARMA.NS,income,2021-03-31 00:00:00,Basic EPS,7.39
SMSPHARMA.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Income,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Tax Provision,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Pretax Income,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Special Income Charges,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Other Special Charges,80000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,9350000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,3144000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Operating Income,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Operating Expense,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Amortization,4337000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Research And Development,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Selling General And Administration,91964000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,50903000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,General And Administrative Expense,41061000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,1043000.0
SMSPHARMA.NS,income,2021-03-31 00:00:00,Gross Profit,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Total Revenue,
SMSPHARMA.NS,income,2021-03-31 00:00:00,Operating Revenue,
